powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1760795660
Nusayba Bagegni
MD
Medical Oncology
Saint Louis,
MO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
1,289
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
31
Brand share
25.3%
Top prescribed drugs
Anastrozole
357 claims
Letrozole
191 claims
Palbociclib
115 claims
Tamoxifen Citrate
80 claims
Apixaban
51 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
84.2
Quality
71.6
Cost
75.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
403
Unique beneficiaries
—
Total services
1,160
Distinct HCPCS
18
Medicare payment
$33K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 109 Medical Oncology providers in MO — above median (cohort median 16,285).
